Argani, Pedram
The Johns Hopkins Hospital,
United States
2025 Rank: 14339
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 18 out of 25326 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14339 | 14242 |
| Total Cites | 1798 | 1993 |
| H-index | 17 | 18 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 30 | 31 |
| Number of Single+First Authored Papers | 84 | 84 |
| Total Cites to Single+First Authored Papers | 358 | 398 |
| Number of Single+First+Last Authored Papers | 172 | 172 |
| Total Cites to Single+First+Last Authored Papers | 571 | 630 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1284 | 1348 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.48 |
| Self-Citation Percentage |
9.78%
|
|
Argani, Pedram
Johns Hopkins University School of Medicine,
United States
2024 Rank: 11094
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 16 out of 24457 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11094 | 10523 |
| Total Cites | 1850 | 2037 |
| H-index | 19 | 20 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 47 | 51 |
| Number of Single+First Authored Papers | 82 | 82 |
| Total Cites to Single+First Authored Papers | 334 | 367 |
| Number of Single+First+Last Authored Papers | 165 | 165 |
| Total Cites to Single+First+Last Authored Papers | 534 | 585 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1381 | 1459 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.40 |
| Self-Citation Percentage |
9.18%
|
|
Argani, Pedram
Johns Hopkins Medical Institutions,
United States
2023 Rank: 12207
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 20 out of 23576 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 12207 | 9879 |
| Total Cites | 2122 | 2477 |
| H-index | 19 | 21 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 28 | 30 |
| Number of Single+First Authored Papers | 79 | 79 |
| Total Cites to Single+First Authored Papers | 345 | 426 |
| Number of Single+First+Last Authored Papers | 161 | 161 |
| Total Cites to Single+First+Last Authored Papers | 571 | 710 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1574 | 1665 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.49 |
| Self-Citation Percentage |
14.33%
|
|
Argani, Pedram
Johns Hopkins School of Medicine,
United States
2022 Rank: 10293
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 19 out of 23010 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10293 | 8761 |
| Total Cites | 2229 | 2554 |
| H-index | 19 | 21 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 31 | 36 |
| Number of Single+First Authored Papers | 71 | 71 |
| Total Cites to Single+First Authored Papers | 374 | 432 |
| Number of Single+First+Last Authored Papers | 151 | 151 |
| Total Cites to Single+First+Last Authored Papers | 611 | 714 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1718 | 1807 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.41 |
| Self-Citation Percentage |
12.73%
|
|
Argani, Pedram
Johns Hopkins Medical Institutions,
United States
2021 Rank: 8214
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 15 out of 22656 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8214 | 6963 |
| Total Cites | 3581 | 4059 |
| H-index | 26 | 28 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 44 | 51 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 638 | 761 |
| Number of Single+First+Last Authored Papers | 148 | 148 |
| Total Cites to Single+First+Last Authored Papers | 1045 | 1233 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2686 | 2824 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.44 |
| Self-Citation Percentage |
11.78%
|
|
Argani, Pedram
Johns Hopkins School of Medicine,
United States
2020 Rank: 9312
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 16 out of 19713 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9312 | 8888 |
| Total Cites | 2666 | 3017 |
| H-index | 22 | 22 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 33 | 37 |
| Number of Single+First Authored Papers | 65 | 65 |
| Total Cites to Single+First Authored Papers | 420 | 505 |
| Number of Single+First+Last Authored Papers | 143 | 143 |
| Total Cites to Single+First+Last Authored Papers | 701 | 819 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2040 | 2175 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.39 |
| Self-Citation Percentage |
11.63%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.